The first known large-scale review of international studies on the positive effect of blood pressure (BP) medicines across all classes in preventing migraine shows these widely available drugs could be used much more widely, at low cost, than is the case with current practice, according to a new paper published today in the journal, Cephalalgia.
Rohto Pharmaceutical Co Ltd Patent: Ophthalmic Composition for Treating Myopia
Share this article According to GlobalData’s company profile on Rohto Pharmaceutical, Nanoemulsion cosmetics was a key innovation area identified from patents. Rohto Pharmaceutical‘s grant share